Home >> Tag Archives: Caris Life Sciences—

Tag Archives: Caris Life Sciences—

Caris presents patient tumor profiling study, 2/14

February—Caris Life Sciences presented a study at the December 2013 CTCR-AACR San Antonio Breast Cancer Symposium on identifying potentially actionable therapeutic targets and clinical strategies for triple-negative breast cancer (TNBC). The biomarker data used for the study were obtained using the company’s tumor profiling service, Caris Molecular Intelligence.

Read More »